Pulmonary fibrosis (PF) is characterized by profound scarring and poor survival. We investigated
the association of leukocyte telomere length (LTL) with chronological age and mortality …

A screen of the Saccharomyces cerevisiae deletion strain set was performed to identify genes
affecting hydrogen sulfide (H 2 S) production. Mutants were screened using two assays: …

Background Progressive fibrosing interstitial lung disease (ILD) is characterised by
parenchymal scar formation, leading to high morbidity and mortality. The ability to predict this …

Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterised by
progressive scarring leading to alveolar stiffness, reduced lung capacity, and impeded gas …

EGCG and Pulmonary Fibrosis Nine patients who were scheduled to undergo lung biopsy
for pulmonary fibrosis were given epigallocatechin gallate (EGCG) for 2 weeks. Levels of …

Respiratory viral infections such as human rhinovirus (HRV) can lead to substantial morbidity
and mortality, especially in people with underlying lung diseases such as asthma and …

Recent prospective clinical trials have shown antifibrotic therapies slow lung function
decline in patients with idiopathic pulmonary fibrosis (IPF) [1, 2] and progressive fibrosing …

Background Studies suggest a harmful pharmacogenomic interaction exists between short
leukocyte telomere length (LTL) and immunosuppressants in idiopathic pulmonary fibrosis (…

Rationale: Idiopathic pulmonary fibrosis (IPF) is a rare, irreversible, and progressive
disease of the lungs. Common genetic variants, in addition to nongenetic factors, have been …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by
limited treatment options and high mortality. A better understanding of the molecular drivers of …